Owing to intrinsic limitations of network meta-analysis, we avoided to analyze the effects of these drugs in several subgroupse.g., as stratified by age or the presence of CV disease or type 2 diabetesto avoid type 1 error due to the many subgroup analyses
Focus on what you can change first - getting them moving, losing weight, and sleeping better
Notable Adopters Private Label and Contract Manufacturers: Positioned to Benefit Consumer-facing brands are often the focus when discussing GLP-1s and M&A activity
Important Clarification: Is Miralax better than Metamucil for weight loss side effects
If you are considering a GLP-1 receptor agonist and are interested in potential anti-inflammatory benefits, several important factors should guide the conversation with your GP or diabetes specialist
In short, he treated her as much more than just a neuro patient, but as a person